Terrill Bravender Jr
David S Rosen M.D. Collegiate Professor of Adolescent Medicine
Clinical Professor of Pediatrics
Clinical Professor of Psychiatry
Section Head, Adolescent Medicine and Associate Chair, Department of Pediatrics
Pediatrics
1500 E. Medical Center Dr, #D2103
Ann Arbor, MI 48109-5718
[email protected]

Available to mentor

Terrill Bravender Jr
Clinical Professor
  • About
  • Qualifications
  • Research Overview
  • Recent Publications
  • About

    Terrill Bravender, MD, MPH is the David S Rosen MD Collegiate Professor of Adolescent Medicine, Professor of Pediatrics, Professor of Psychiatry, and the Division Director of Adolescent Medicine at the University of Michigan in Ann Arbor. He is the Executive Director of the Comprehensive Eating Disorders Program, Co-Medical Director of the University of Michigan Adolescent Health Initiative, and also serves as the Associate Chair for Faculty Affairs in the Department of Pediatrics. Dr. Bravender is a graduate of the University of Michigan and Harvard University, and previously held faculty appointments at Harvard, Duke, and Ohio State University. He has published more than 100 articles, book chapters, and books in the field of adolescent health and eating disorders. Dr. Bravender is active in the Society for Adolescent Health and Medicine, the Society for Pediatric Research, and the American Board of Pediatrics.

    Qualifications
    • Residency
      Duke University School of Medicine, Pediatrics
    • Chief Residency
      Duke University School of Medicine, Pediatrics
    • Fellowship
      Boston Children's Hospital, Adolescent Medicine
    • MPH
      Harvard University, Boston, 1999
    • MD
      University of Michigan, Ann Arbor, 1992
    • BS
      University of Michigan, Ann Arbor, 1990
    Research Overview

    Medical management of adolescent eating disorders
    Treatment outcomes in adolescent eating disorders
    Workforce equity in healthcare

    Recent Publications See All Publications
    • Journal Article
      Advancements in Inpatient Medical Management of Malnutrition in Children and Adolescents with Restrictive Eating Disorders.
      Stoody VB, Garber AK, Miller CA, Bravender T. J Pediatr, 2023 Sep; 260: 113482 DOI:10.1016/j.jpeds.2023.113482
      PMID: 37196778
    • Journal Article
      78. Estimating Goal Weights in Adolescents with Anorexia Nervosa and Atypical Anorexia Nervosa: Comparison of the Median BMI and Historical BMI Percentile
      Jary JM, Winnie SL, Bravender T, Prohaska N, Van Huysse JL. Journal of Adolescent Health, 2023 Mar; 72 (3): s46 DOI:10.1016/j.jadohealth.2022.11.099
    • Journal Article
      50 Years Ago in TheJournalofPediatrics: Pediatric Nurse Practitioners: 50 Years of Partnering for Children's Health.
      Wagner J, Bravender T. J Pediatr, 2023 Jan; 252: 75 DOI:10.1016/j.jpeds.2022.11.004
      PMID: 36521975
    • Journal Article
      Adolescent eating disorder treatment outcomes of an in-person partial hospital program versus a virtual intensive outpatient program.
      Van Huysse JL, Prohaska N, Miller C, Jary J, Sturza J, Etsell K, Bravender T. Int J Eat Disord, 2023 Jan; 56 (1): 192 - 202. DOI:10.1002/eat.23866
      PMID: 36444727
    • Proceeding / Abstract / Poster
      Estimating Treatment Goal Weights in Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa: Comparison of the Median BMI and Historical BMI Percentile.
      Jary Franklin JM, Winnie SL, Prohaska N, Bravender T, Van Huysse JL. Int J Eat Disord, 2024 Sep 26; DOI:10.1002/eat.24298
      PMID: 39324372
    • Journal Article
      50 Years Ago in TheJournalofPediatrics: Mobile Health Care for At-Risk Youth: Still a Road Less Traveled.
      Stoody VB, Bravender T. J Pediatr, 2022 Nov; 250: 37 DOI:10.1016/j.jpeds.2022.08.048
      PMID: 36376009
    • Journal Article
      50 Years Ago in TheJournalofPediatrics: Accidental Ingestion of LSD: Everything Old Is New Again.
      Bravender T. J Pediatr, 2022 May; 244: 57 DOI:10.1016/j.jpeds.2022.01.020
      PMID: 35534163
    • Presentation
      Program Moderator: Adolescent Medicine I (platform)
      2022 Apr 1;